| ¿ Cuál es el paciente candidato a tratamiento con efalizumab y por qué? L Puig Actas Dermo-Sifiliográficas 99, 51-61, 2008 | | 2008 |
| ¿ Es realmente útil el PASI como parámetro de la gravedad de la psoriasis? L Puig Piel 22 (8), 367-369, 2007 | 5 | 2007 |
| ¿ Es realmente útil el PASI como parámetro de medida de severidad en la psoriasis L Puig Servicio de Dermatología. Hospital de la Santa Creu I Sant Pau, Barcelona, 2008 | 4 | 2008 |
| " Lupus erythematosus-like" oriental sore with multiple lesions: treatment with itraconazole. JM Casanova, M Metaute, R Egido, J Romaní, C Muñoz, LL Puig | | 1998 |
| [[Artículo traducido]] Tratamiento comparativo de lesiones mucocutáneas en pacientes con telangiectasia hemorrágica hereditaria con láser dual secuencial de colorante pulsado y … X Cubiró, C Garcia-Melendo, CE Morales-Munera, A Riera-Mestre, ... Actas Dermo-Sifiliográficas, 2024 | | 2024 |
| [Translated article] Nail Psoriasis E Canal-García, X Bosch-Amate, I Belinchón, L Puig Actas Dermo-Sifiliográficas 113 (5), T481-T490, 2022 | 2 | 2022 |
| [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of … JM Carrascosa, L Puig, IB Romero, L Salgado-Boquete, E Del Alcázar, ... Actas dermo-sifiliograficas 113 (6), T583-T609, 2022 | 10 | 2022 |
| [Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of … JM Carrascosa, L Puig, IB Romero, L Salgado-Boquete, E Del Alcázar, ... Actas dermo-sifiliograficas 113 (3), T261-T277, 2022 | 25 | 2022 |
| [Translated article] Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classification in Dermatology L Puig Actas dermo-sifiliograficas 114 (10), T847-T849, 2023 | | 2023 |
| [Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis R Ruiz-Villaverde, M Galán-Gutiérrez, M Llamas-Velasco, ... Actas dermo-sifiliograficas 114 (6), T494-T501, 2023 | 3 | 2023 |
| <> oriental sore with multiple lesions Treatment with Itraconazol JM Casanova, M Metaute, R Egido, J Romani, C Munoz, LL Puig Medicina Cutanea Ibero Latino Americana 26 (1), 42-48, 1998 | | 1998 |
| 1: Rodríguez Galindo C, Luelmo Aguilar J, Boronat Rom M, Malvehy Rovira J, Fito Costas A, Carrascosa Lezcano A.[Cutaneous periarteritis nodosa in children. Apropos of a case … M Sánchez-Regaña, M Alsina, V García-Patos, EP Grupo | | |
| 1077 Italian expert consensus for the management of actinic keratosis in immunocompetent patients K Peris, PG Calzavara-Pinton, L Neri, G Girolomoni, G Malara, A Parodi, ... | | |
| 120 kg pourrait constituer un seuil de poids corporel approprié pour l’utilisation de la dose plus élevée de tildrakizumab: analyses groupées des essais de phase 3 reSURFACE 1 … D Thaçi, S Gerdes, KG Du Jardin, JL Perrot, L Puig Annales de Dermatologie et de Vénéréologie-FMC 2 (8), A325, 2022 | | 2022 |
| 13634 Tildrakizumab provides early predictability of response in patients with moderate to severe psoriasis: Results from reSURFACE 1 and reSURFACE 2 phase 3 trials RB Warren, L Iversen, L Puig, E Fumero, AS López, SR Feldman Journal of the American Academy of Dermatology 83 (6), AB10, 2020 | | 2020 |
| 14027 Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial K Papp, M Lebwohl, J Zeng, S Rubant, J Valdes, C Leonardi Journal of the American Academy of Dermatology 83 (6), AB17, 2020 | | 2020 |
| 15807 Efficacy of tildrakizumab in patients with moderate to severe psoriasis according to disease duration: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials at … D Thaçi, L Iversen, I Pau-Charles, AS López, A Blauvelt, L Puig Journal of the American Academy of Dermatology 83 (6), AB160, 2020 | | 2020 |
| 17. The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12-17 with Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial AS Paller, JI Silverberg, HH Chih-ho, M Cork, L Puig, P Arlert, A Kurbasic, ... Journal of Dermatology for Physician Assistants 16 (4), 58-59, 2022 | | 2022 |
| 17817 Prospective observational study to evaluate the benefits for the patient associated with the treatment of plaque psoriasis with apremilast after other systemic treatments … P de la Cueva Dobao, SA Alonso, M Llamas-Velasco, R Rivera, ... Journal of the American Academy of Dermatology 83 (6), AB200, 2020 | | 2020 |
| 220. Ustekinumab Improves Physical Function, General as Well as Arthritis-Related and Skin-Related Quality of Life and Work Productivity of Patients with Active Psoriatic … AB Gottlieb, P Rahman, A Kavanaugh, IB McInnes, C Ritchlin, S Li, ... Rheumatology 53 (suppl_1), i142-i142, 2014 | | 2014 |
MT Fernández-FiguerasAssociate Professor Universitat Internacional de Catalunya在 quironsalud.es 的电子邮件经过验证
